Genomill Strengthens Leadership Team: Erno Sundberg Appointed COO, Juha-Pekka Pursiheimo Named CTO, and Manu Tamminen Confirmed as CEO

Turku, Finland – 24.4.2025 – Genomill Health Oy, a pioneer in next-generation DNA technologies, is pleased to announce several key leadership appointments that mark a new chapter in the company’s growth. Erno Sundberg has been appointed Chief Operating Officer (COO), Juha-Pekka Pursiheimo has been promoted to Chief Technology Officer (CTO), and Manu Tamminen, previously serving as interim CEO, has been named the company’s Chief Executive Officer.

Sundberg brings extensive operational and strategic experience in diagnostics and life sciences, having previously served as CEO of Abacus Diagnostica Oy and Business Director at Uniogen Oy, where he led initiatives in molecular diagnostics. At Genomill, his role will be instrumental as the company transitions from R&D to commercial execution and global scaling of its Geno1® technologies.

Juha-Pekka Pursiheimo, PhD, a seasoned scientific leader and long-time force behind Genomill’s innovation, will take on the role of CTO, driving forward the industrialization and scalability of the company’s proprietary DNA sequencing workflows. His deep technical expertise and leadership have been foundational in the evolution of Genomill’s platform.

Manu Tamminen, PhD, co-founder and scientific visionary behind Genomill, has now officially been appointed CEO after successfully guiding the company through its recent growth and technology milestones in an interim capacity.

“These leadership appointments reflect the confidence we have in the direction Genomill is heading,” said Sami Savisalo, Chairman of the Board. “With Manu’s visionary leadership, Juha-Pekka’s technical excellence, and Erno’s operational depth, we are building a world-class executive team ready to take Genomill into its next phase of global growth.”

“We are excited to welcome Erno to the Genomill team,” said Manu Tamminen, CEO of Genomill. “As we shift toward commercial execution and scale our Geno1 technologies globally, Erno’s experience will be a key driver in realizing our strategic ambitions.”

“I’m thrilled to join Genomill at such a pivotal time,” added Erno Sundberg, newly appointed COO. “The company’s technology has the potential to redefine the landscape of DNA sequencing and diagnostics. I look forward to helping scale its impact globally and build a world-class operation that supports innovation at every level.”